Chapter 47 : Molecular Approaches for Diagnosis of Chagas’ Disease and Genotyping of

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Molecular Approaches for Diagnosis of Chagas’ Disease and Genotyping of , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816834/9781555814977_Chap47-1.gif /docserver/preview/fulltext/10.1128/9781555816834/9781555814977_Chap47-2.gif


Molecular approaches have been shown to be valuable tools contributing to the diagnosis of congenital infection and to the follow-up of infected patients having received trypanocidal drugs, as well as for identifying lineages and sublineages of . In the first part of this chapter molecular analyses are considered as diagnostic tools at the individual and/or epidemiological level; this is followed, in the second part, by detailed protocols for detecting DNA using qualitative PCR and quantitative PCR (qPCR) as well as identifying (sub)lineages by hybridization with specific DNA probes. PCR could help in the diagnosis of infection/Chagas’ disease or in the management of infected patients in three main cases: (i) the diagnosis of congenital infection, (ii) the early detection of a reactivation of Chagas’ disease in immunosuppressed patients, and (iii) the follow-up of infected patients treated with antiparasitic drugs. PCR, particularly qPCR, was also demonstrated to be useful for the early diagnosis of Chagas’ disease reactivation in immunosuppressed patients. The detection of DNA is made with the SYBR Green fluorophore, an intercalating dye, fluorescing only when bound to dsDNA. The fluorescence of each sample is measured after each cycle. The SYBR Green signal measured is proportional to the dsDNA synthesized de novo in the course of the PCR cycles. High specificity of amplification is mandatory and must be assessed at the end of the amplification by electrophoresis or by analysis of the melting curves of the amplicons.

Citation: Svoboda M, Virreira M, Truyens C, Torrico F, Carlier Y. 2011. Molecular Approaches for Diagnosis of Chagas’ Disease and Genotyping of , p 713-725. In Persing D, Tenover F, Tang Y, Nolte F, Hayden R, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555816834.ch47

Key Concept Ranking

Random Amplified Polymorphic DNA
Restriction Fragment Length Polymorphism
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Anonymous. 1999. Recommendations from a satellite meeting. Mem. Inst. Oswaldo Cruz 94(Suppl. 1):429432.
2. Avila, H. A.,, D. S. Sigman,, L. M. Cohen,, R. C. Millikan, and, L. Simpson. 1991. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas’ disease. Mol. Biochem. Parasitol. 48:211221.
3. Avila, H. A.,, and L. Simpson. 1995. Organization and complexity of minicircle-encoded guide RNAs in Trypanosoma cruzi. RNA 1:939947.
4. Breniere, S. F.,, M. F. Bosseno,, S. Revollo,, M. T. Rivera,, Y. Carlier, and, M. Tibayrenc. 1992. Direct identification of Trypanosoma cruzi natural clones in vectors and mammalian hosts by polymerase chain reaction amplification. Am. J. Trop. Med. Hyg. 46:335341.
5. Breniere, S. F.,, M. F. Bosseno,, J. Telleria,, B. Bastrenta,, N. Yacsik,, F. Noireau,, J. L. Alcazar,, C. Barnabe,, P. Wincker, and, M. Tibayrenc. 1998. Different behavior of two Trypanosoma cruzi major clones: transmission and circulation in young Bolivian patients. Exp. Parasitol. 89:285295.
6. Breniere, S. F.,, W. Morochi,, M. F. Bosseno,, J. Ordonez,, T. Gutierrez,, F. Vargas,, N. Yaksic, and, F. Noireau. 1998. Trypanosoma cruzi genotypes associated with domestic Triatoma sordida in Bolivia. Acta Trop. 71:269283.
7. Brisse, S.,, C. Barnabe, and, M. Tibayrenc. 2000. Identification of six Trypanosoma cruzi phylogenetic lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis. Int. J. Parasitol. 30:3544.
8. Brisse, S.,, J. C. Dujardin, and, M. Tibayrenc. 2000. Identification of six Trypanosoma cruzi lineages by sequencecharacterised amplified region markers. Mol. Biochem. Parasitol. 111:95105.
9. Britto, C.,, M. A. Cardoso,, C. Ravel,, A. Santoro,, J. B. Pereira,, J. R. Coura,, C. M. Morel, and, P. Wincker. 1995. Trypanosoma cruzi: parasite detection and strain discrimination in chronic chagasic patients from northeastern Brazil using PCR amplification of kinetoplast DNA and nonradioactive hybridization. Exp. Parasitol. 81:462471.
10. Britto, C.,, M. A. Cardoso,, P. Wincker, and, C. M. Morel. 1993. A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR)-based diagnosis of chronic Chagas’ disease. Mem. Inst. Oswaldo Cruz 88:171172.
11. Brutus, L.,, D. Schneider,, J. Postigo,, M. Romero,, J. Santalla, and, J. P. Chippaux. 2008. Congenital Chagas’ disease: diagnostic and clinical aspects in an area without vectorial transmission, Bermejo, Bolivia. Acta Trop. 106:195199.
12. Buekens, P.,, O. Almendares,, Y. Carlier,, E. Dumonteil,, M. Eberhard,, R. Gamboa-Leon,, M. James,, N. Padilla,, D. Wesson, and, X. Xiong. 2008. Mother-to-child transmission of Chagas’ disease in North America: why don’t we do more? Matern. Child Health J. 12:283286.
13. Burgos, J. M.,, J. Altcheh,, M. Bisio,, T. Duffy,, H. M. Valadares,, M. E. Seidenstein,, R. Piccinali,, J. M. Freitas,, M. J. Levin,, L. Macchi,, A. M. Macedo,, H. Freilij, and, A. G. Schijman. 2007. Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas’ disease. Int. J. Parasitol. 37:13191327.
14. Caballero, Z. C.,, O. E. Sousa,, W. P. Marques,, A. Saez-Alquezar, and, E. S. Umezawa. 2007. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin. Vaccine Immunol. 14:10451049.
15. Campbell, D. A.,, N. R. Sturm, and, M. C. Yu. 2000. Transcription of the kinetoplastid spliced leader RNA gene. Parasitol. Today 16:7882.
16. Campos, R. F.,, M. L. Guerreiro,, K. S. Sobral,, R. C. Lima, and, S. G. Andrade. 2005. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme type II, Trypanosoma cruzi II). Rev. Soc. Bras. Med. Trop. 38:142146.
17. Cancado, J. R. 2002. Long term evaluation of etiological treatment of Chagas’ disease with benznidazole. Rev. Inst. Med. Trop. São Paulo 44:2937.
18. Carlier, Y.,, J. C. Pinto Dias,, A. O. Ostermayer Luquetti,, M. Hontebeyrie,, F. Torrico, and, C. Truyens. 2002. Trypanosomiase américaine ou maladie de Chagas’. Encycl. Med. Chirurg. 8:505520.
19. Carlier, Y.,, and F. Torrico. 2003. Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Rev. Soc. Bras. Med. Trop. 36:767771.
20. Carme, B.,, I. Aune,, G. Nguyen,, C. Aznar, and, B. Beaudet. 2001. Four cases of acute chagasic myocarditis in French Guiana. Am. J. Trop. Med. Hyg. 64:162163.
21. Centurion-Lara, A.,, L. Barrett, and, W. C. Van Voorhis. 1994. Quantitation of parasitemia by competitive polymerase chain reaction amplification of parasite kDNA minicircles during chronic infection with Trypanosoma cruzi. J. Infect. Dis. 170:13341339.
22. Cheng, K. Y.,, C. D. Chang,, V. A. Salbilla,, L. V. Kirchhoff,, D. A. Leiby,, G. Schochetman, and, D. O. Shah. 2007. Immunoblot assay using recombinant antigens as a supplemental test to confirm the presence of antibodies to Trypanosoma cruzi. Clin. Vaccine Immunol. 14:355361.
23. Clayton, C. E. 2002. Life without transcriptional control? From fly to man and back again. EMBO J. 21:18811888.
24. Coronado, X.,, I. Zulantay,, M. Rozas,, W. Apt,, G. Sanchez,, J. Rodriguez,, S. Ortiz, and, A. Solari. 2006. Dissimilar distribution of Trypanosoma cruzi clones in humans after chemotherapy with allopurinol and itraconazole. J. Antimicrob. Chemother. 58:216219.
25. Coura, J. R.,, A. C. Junqueira,, O. Fernandes,, S. A. Valente, and, M. A. Miles. 2002. Emerging Chagas’ disease in Amazonian Brazil. Trends Parasitol. 18:171176.
26. Cummings, K. L.,, and R. L. Tarleton. 2003. Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol. Biochem. Parasitol. 129:5359.
27. Degrave, W.,, S. P. Fragoso,, C. Britto,, H. van Heuverswyn,, G. Z. Kidane,, M. A. Cardoso,, R. U. Mueller,, L. Simpson, and, C. M. Morel. 1988. Peculiar sequence organization of kinetoplast DNA minicircles from Trypanosoma cruzi. Mol. Biochem. Parasitol. 27:6370.
28. Diaz, C.,, V. Nussenzweig, and, A. Gonzalez. 1992. An improved polymerase chain reaction assay to detect Trypanosoma cruzi in blood. Am. J. Trop. Med. Hyg. 46:616623.
29. Diez, C. N.,, S. Manattini,, J. C. Zanuttini,, O. Bottasso, and, I. Marcipar. 2008. The value of molecular studies for the diagnosis of congenital Chagas’ disease in northeastern Argentina. Am. J. Trop. Med. Hyg. 78:624627.
30. Diez, M.,, L. Favaloro,, A. Bertolotti,, J. M. Burgos,, C. Vigliano,, M. P. Lastra,, M. J. Levin,, A. Arnedo,, C. Nagel,, A. G. Schijman, and, R. R. Favaloro. 2007. Usefulness of PCR strategies for early diagnosis of Chagas’ disease reactivation and treatment follow-up in heart transplantation. Am. J. Transplant. 7:16331640.
31. Di Noia, J. M.,, C. A. Buscaglia,, C. R. De Marchi,, I. C. Almeida, and, A. C. Frasch. 2002. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas’ disease is due to a single parasite lineage. J. Exp. Med. 195:401413.
32. El Sayed, N. M.,, P. J. Myler,, D. C. Bartholomeu,, D. Nilsson,, G. Aggarwal,, A. N. Tran,, E. Ghedin,, E. A. Worthey,, A. L. Delcher,, G. Blandin,, S. J. Westenberger,, E. Caler,, G. C. Cerqueira,, C. Branche,, B. Haas,, A. Anupama,, E. Arner,, L. Aslund,, P. Attipoe,, E. Bontempi,, F. Bringaud,, P. Burton,, E. Cadag,, D. A. Campbell,, M. Carrington,, J. Crabtree,, H. Darban,, J. F. da Silveira,, P. de Jong,, K. Edwards,, P. T. Englund,, G. Fazelina,, T. Feld-blyum,, M. Ferella,, A. C. Frasch,, K. Gull,, D. Horn,, L. Hou,, Y. Huang,, E. Kindlund,, M. Klingbeil,, S. Kluge,, H. Koo,, D. Lacerda,, M. J. Levin,, H. Lorenzi,, T. Louie,, C. R. Machado,, R. McCulloch,, A. McKenna,, Y. Mizuno,, J. C. Mottram,, S. Nelson,, S. Ochaya,, K. Osoegawa,, G. Pai,, M. Parsons,, M. Pentony,, U. Pettersson,, M. Pop,, J. L. Ramirez,, J. Rinta,, L. Robertson,, S. L. Salzberg,, D. O. Sanchez,, A. Seyler,, R. Sharma,, J. Shetty,, A. J. Simpson,, E. Sisk,, M. T. Tammi,, R. Tarleton,, S. Teixeira,, S. Van Aken,, C. Vogt,, P. N. Ward,, B. Wickstead,, J. Wortman,, O. White,, C. M. Fraser,, K. D. Stuart, and, B. Andersson. 2005. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas’ disease. Science 309:409415.
33. El Sayed, N. M.,, P. J. Myler,, G. Blandin,, M. Berriman,, J. Crabtree,, G. Aggarwal,, E. Caler,, H. Renauld,, E. A. Worthey,, C. Hertz-Fowler,, E. Ghedin,, C. Peacock,, D. C. Bartholomeu,, B. J. Haas,, A. N. Tran,, J. R. Wortman,, U. C. Alsmark,, S. Angiuoli,, A. Anupama,, J. Badger,, F. Bringaud,, E. Cadag,, J. M. Carlton,, G. C. Cerqueira,, T. Creasy,, A. L. Delcher,, A. Djikeng,, T. M. Embley,, C. Hauser,, A. C. Ivens,, S. K. Kummerfeld,, J. B. Pereira-Leal,, D. Nilsson,, J. Peterson,, S. L. Salzberg,, J. Shallom,, J. C. Silva,, J. Sundaram,, S. Westenberger,, O. White,, S. E. Melville,, J. E. Donelson,, B. Andersson,, K. D. Stuart, and, N. Hall. 2005. Comparative genomics of trypanosomatid parasitic protozoa. Science 309:404409.
34. Feilij, H.,, L. Muller, and, S. M. Gonzalez Cappa. 1983. Direct micromethod for diagnosis of acute and congenital Chagas’ disease. J. Clin. Microbiol. 18:327330.
35. Fernandes, O.,, N. R. Sturm,, R. Derre, and, D. A. Campbell. 1998. The mini-exon gene: a genetic marker for zymodeme III of Trypanosoma cruzi. Mol. Biochem. Parasitol. 95:129133.
36. Gaunt, M. W.,, M. Yeo,, I. A. Frame,, J. R. Stothard,, H. J. Carrasco,, M. C. Taylor,, S. S. Mena,, P. Veazey,, G. A. Miles,, N. Acosta,, A. R. de Arias, and, M. A. Miles. 2003. Mechanism of genetic exchange in American trypanosomes. Nature 421:936939.
37. Gomes, M. L.,, L. M. Galvao,, A. M. Macedo,, S. D. Pena, and, E. Chiari. 1999. Chagas’ disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods. Am. J. Trop. Med. Hyg. 60:205210.
38. Gomes, M. L.,, A. M. Macedo,, A. R. Vago,, S. D. Pena,, L. M. Galvao, and, E. Chiari. 1998. Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. Exp. Parasitol. 88:2833.
39. Gorlin, J.,, S. Rossmann,, G. Robertson,, F. Stallone,, N. Hirschler,, K. A. Nguyen,, R. Gilcher,, H. Fernandes,, S. Alvey,, P. Ajongwen,, P. Contestable, and, H. Warren. 2008. Evaluation of a new Trypanosoma cruzi antibody assay for blood donor screening. Transfusion (Paris) 48:531540.
40. Higo, H.,, S. Miura,, T. Agatsuma,, T. Mimori,, T. Yanagi,, M. Iwagami,, A. R. de Arias,, V. Matta,, K. Hirayama,, T. Takeuchi,, I. Tada, and, K. Himeno. 2007. Identification of Trypanosoma cruzi sublineages by the simple method of single-stranded conformation DNA polymorphism (SSCP). Parasitol. Res. 100:10231031.
41. Macedo, A. M.,, C. R. Machado,, R. P. Oliveira, and, S. D. Pena. 2004. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas’ disease. Mem. Inst. Oswaldo Cruz 99:112.
42. Machado, C. A.,, and F. J. Ayala. 2001. Nucleotide sequences provide evidence of genetic exchange among distantly related lineages of Trypanosoma cruzi. Proc. Natl. Acad. Sci. USA 98:73967401.
43. Marcon, G. E.,, P. D. Andrade,, D. M. de Albuquerque,, J. S. Wanderley,, E. A. de Almeida,, M. E. Guariento, and, S. C. Costa. 2002. Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagn. Microbiol. Infect. Dis. 43:3943.
44. Marin-Neto, J. A.,, A. Rassi, Jr.,, C. A. Morillo,, A. Avezum,, S. J. Connolly,, S. Sosa-Estani,, F. Rosas, and, S. Yusuf. 2008. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas’ cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am. Heart J. 156:3743.
45. Martins, H. R.,, R. M. Silva,, H. M. Valadares,, M. J. Toledo,, V. M. Veloso,, D. M. Vitelli-Avelar,, C. M. Carneiro,, G. L. Machado-Coelho,, M. T. Bahia,, O. A. Martins-Filho,, A. M. Macedo, and, M. Lana. 2007. Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi. Antimicrob. Agents Chemother. 51:32823289.
46. Miles, M. A.,, A. Souza,, M. Povoa,, J. J. Shaw,, R. Lainson, and, P. J. Toye. 1978. Isozymic heterogeneity of Trypanosoma cruzi in the first autochthonous patients with Chagas’ disease in Amazonian Brazil. Nature 272:819821.
47. Mora, M. C.,, N. O. Sanchez,, D. Marco,, A. Barrio,, M. Ciaccio,, M. A. Segura, and, M. A. Basombrio. 2005. Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology. J. Parasitol. 91:14681473.
48. Moser, D. R.,, L. V. Kirchhoff, and, J. E. Donelson. 1989. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J. Clin. Microbiol. 27:14771482.
49. Pan American Health Organization (PAHO). 2006. Estimación cuantitativa de la enfermedad de Chagas en las Américas, OPS/HDM/CD/425-06. Pan American Health Organization (PAHO), WHO, Department of Control of Neglected Tropical Diseases, Montevideo, Uruguay.
50. Picka, M. C.,, D. A. Meira,, T. B. de Carvalho,, E. Peresi, and, J. Marcondes-Machado. 2007. Definition of a diagnostic routine in individuals with inconclusive serology for Chagas’ disease. Braz. J. Infect. Dis. 11:226233.
51. Piron, M.,, R. Fisa,, N. Casamitjana,, P. Lopez-Chejade,, L. Puig,, M. Verges,, J. Gascon,, J. G. Prat,, M. Portus, and, S. Sauleda. 2007. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop. 103:195200.
52. Pizarro, J. C.,, D. E. Lucero, and, L. Stevens. 2007. PCR reveals significantly higher rates of Trypanosoma cruzi infection than microscopy in the Chagas’ vector, Triatoma infestans: high rates found in Chuquisaca, Bolivia. BMC Infect. Dis. 7:66.
53. Ponce, C.,, E. Ponce,, E. Vinelli,, A. Montoya,, V. de Aguilar,, A. Gonzalez,, B. Zingales,, R. Rangel-Aldao,, M. J. Levin,, J. Esfandiari,, E. S. Umezawa,, A. O. Luquetti, and, J. F. da Silveira. 2005. Validation of a rapid and reliable test for diagnosis of Chagas’ disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. J. Clin. Microbiol. 43:50655068.
54. Prata, A. 2001. Clinical and epidemiological aspects of Chagas’ disease. Lancet Infect. Dis. 1:92100.
55. Rozas, M.,, S. De Doncker,, V. Adaui,, X. Coronado,, C. Barnabe,, M. Tibyarenc,, A. Solari, and, J. C. Dujardin. 2007. Multilocus polymerase chain reaction restriction fragment length polymorphism genotyping of Trypanosoma cruzi (Chagas’ disease): taxonomic and clinical applications. J. Infect. Dis. 195:13811388.
56. Russomando, G.,, M. M. C. de Tomassone,, I. de Guillen,, N. Acosta,, N. Vera,, M. Almiron,, N. Candia,, M. F. Calcena, and, A. Figueredo. 1998. Treatment of congenital Chagas’ disease diagnosed and followed up by the polymerase chain reaction. Am. J. Trop. Med. Hyg. 59:487491.
57. Sambrook, J.,, E. F. Fritsch, and, T. Maniatis. 1989. Molecular Cloning: a Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
58. Sanchez, N. O.,, F. J. Sanchez Valdez,, C. D. Lacunza,, M. F. Garcia Bustos,, M. C. Mora,, A. D. Uncos, and, M. A. Basombrio. 2008. Serological evaluation of specific-antibody levels in patients treated for chronic Chagas’ disease. Clin. Vaccine Immunol. 15:297302.
59. Schijman, A. G.,, J. Altcheh,, J. M. Burgos,, M. Biancardi,, M. Bisio,, M. J. Levin, and, H. Freilij. 2003. Aetiological treatment of congenital Chagas’ disease diagnosed and monitored by the polymerase chain reaction. J. Antimicrob. Chemother. 52:441449.
60. Schmunis, G. A. 2007. Epidemiology of Chagas’ disease in non-endemic countries: the role of international migration. Mem. Inst. Oswaldo Cruz 102(Suppl. 1):7585.
61. Schofield, C. J.,, J. Jannin, and, R. Salvatella. 2006. The future of Chagas’ disease control. Trends Parasitol. 22:583588.
62. Solari, A.,, R. Campillay,, S. Ortiz, and, A. Wallace. 2001. Identification of Trypanosoma cruzi genotypes circulating in Chilean chagasic patients. Exp. Parasitol. 97:226233.
63. Sosa, E. S.,, E. L. Segura,, A. M. Ruiz,, E. Velazquez,, B. M. Porcel, and, C. Yampotis. 1998. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas’ disease. Am. J. Trop. Med. Hyg. 59:526529.
64. Souto, R. P.,, O. Fernandes,, A. M. Macedo,, D. A. Campbell, and, B. Zingales. 1996. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol. Biochem. Parasitol. 83:141152.
65. Souto, R. P.,, and B. Zingales. 1993. Sensitive detection and strain classification of Trypanosoma cruzi by amplification of a ribosomal RNA sequence. Mol. Biochem. Parasitol. 62:4552.
66. Sturm, N. R.,, W. Degrave,, C. Morel, and, L. Simpson. 1989. Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas’ disease. Mol. Biochem. Parasitol. 33:205214.
67. Sturm, N. R.,, N. S. Vargas,, S. J. Westenberger,, B. Zingales, and, D. A. Campbell. 2003. Evidence for multiple hybrid groups in Trypanosoma cruzi. Int. J. Parasitol. 33:269279.
68. Tibayrenc, M.,, P. Ward,, A. Moya, and, F. J. Ayala. 1986. Natural populations of Trypanosoma cruzi, the agent of Chagas’ disease, have a complex multiclonal structure. Proc. Natl. Acad. Sci. USA 83:115119.
69. Tobler, L. H.,, P. Contestable,, L. Pitina,, H. Groth,, S. Shaffer,, G. R. Blackburn,, H. Warren,, S. R. Lee, and, M. P. Busch. 2007. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas’ antibody in US blood donors. Transfusion (Paris) 47:9096.
70. Torrico, F.,, C. Alonso-Vega,, E. Suarez,, P. Rodriguez,, M. C. Torrico,, M. Dramaix,, C. Truyens, and, Y. Carlier. 2004. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am. J. Trop. Med. Hyg. 70:201209.
71. Torrico, M. C.,, M. Solano,, J. M. Guzman,, R. Parrado,, E. Suarez,, C. Alonso-Vega,, C. Truyens,, Y. Carlier, and, F. Torrico. 2005. Estimación de la parasitemia en la infección humana por T. cruzi las altas parasitemias están asociadas con la severa y fatal enfermedad de Chagas con-génita. Rev. Soc. Bras. Med. Trop. 38:5861.
72. Vago, A. R.,, L. O. Andrade,, A. A. Leite,, R. D. d’Avila,, A. M. Macedo,, S. J. Adad,, S. Tostes, Jr.,, M. C. Moreira,, G. B. Filho, and, S. D. Pena. 2000. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas’ disease: differential distribution of genetic types into diverse organs. Am. J. Pathol. 156:18051809.
73. Valadares, H. M.,, J. R. Pimenta,, J. M. de Freitas,, T. Duffy,, D. C. Bartholomeu,, R. P. Oliveira,, E. Chiari,, M. C. Moreira,, G. B. Filho,, A. G. Schijman,, G. R. Franco,, C. R. Machado,, S. D. Pena, and, A. M. Macedo. 2008. Genetic profiling of Trypanosoma cruzi directly in infected tissues using nested PCR of polymorphic microsatellites. Int. J. Parasitol. 38:839850.
74. Veas, F.,, S. F. Breniere,, G. Cuny,, C. Brengues,, A. Solari, and, M. Tibayrenc. 1991. General procedure to construct highly specific kDNA probes for clones of Trypanosoma cruzi for sensitive detection by polymerase chain reaction. Cell. Mol. Biol. 37:7384.
75. Viotti, R.,, and C. Vigliano. 2007. Etiological treatment of chronic Chagas’ disease: neglected “evidence” by evidence-based medicine. Expert Rev. Anti-Infect. Ther. 5:717726.
76. Virreira, M.,, C. Alonso-Vega,, M. Solano,, J. Jijena,, L. Brutus,, Z. Bustamante,, C. Truyens,, D. Schneider,, F. Torrico,, Y. Carlier, and, M. Svoboda. 2006. Congenital Chagas’ disease in Bolivia is not associated with DNA polymorphism of Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 75:871879.
77. Virreira, M.,, S. Martinez,, C. Alonso-Vega,, F. Torrico,, M. Solano,, M. C. Torrico,, R. Parrado,, C. Truyens,, Y. Carlier, and, M. Svoboda. 2006. Amniotic fluid is not useful for diagnosis of congenital Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 75:10821084.
78. Virreira, M.,, F. Torrico,, C. Truyens,, C. Alonso-Vega,, M. Solano,, Y. Carlier, and, M. Svoboda. 2003. Comparison of polymerase chain reaction methods for reliable and easy detection of congenital Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 68:574582.
79. Virreira, M.,, C. Truyens,, C. Alonso-Vega,, L. Brutus,, J. Jijena,, F. Torrico,, Y. Carlier, and, M. Svoboda. 2007. Comparison of Trypanosoma cruzi lineages and levels of parasitic DNA in infected mothers and their newborns. Am. J. Trop. Med. Hyg. 77:102106.
80. Westenberger, S. J.,, C. Barnabe,, D. A. Campbell, and, N. R. Sturm. 2005. Two hybridization events define the population structure of Trypanosoma cruzi. Genetics 171:527543.
81. Wilkinson, S. R.,, M. C. Taylor,, D. Horn,, J. M. Kelly, and, I. Cheeseman. 2008. A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proc. Natl. Acad. Sci. USA 105:50225027.
82. Wincker, P.,, C. Britto,, J. B. Pereira,, M. A. Cardoso,, W. Oelemann, and, C. M. Morel. 1994. Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. Am. J. Trop. Med. Hyg. 51:771777.
83. Zulantay, I.,, W. Apt,, L. C. Gil,, C. Rocha,, K. Mundaca,, A. Solari,, G. Sanchez,, C. Rodriguez,, G. Martinez,, L. M. De Pablos,, L. Sandoval,, J. Rodriguez,, S. Vilchez, and, A. Osuna. 2007. The PCR-based detection of Trypanosoma cruzi in the faeces of Triatoma infestans fed on patients with chronic American trypanosomiasis gives higher sensitivity and a quicker result than routine xenodiagnosis. Ann. Trop. Med. Parasitol. 101:673679.
84. Zulantay, I.,, P. Honores,, A. Solari,, W. Apt,, S. Ortiz,, A. Osuna,, A. Rojas,, B. Lopez, and, G. Sanchez. 2004. Use of polymerase chain reaction (PCR) and hybridization assays to detect Trypanosoma cruzi in chronic chagasic patients treated with itraconazole or allopurinol. Diagn. Microbiol. Infect. Dis. 48:253257.


Generic image for table

Origin of strains used in our experimental work

Citation: Svoboda M, Virreira M, Truyens C, Torrico F, Carlier Y. 2011. Molecular Approaches for Diagnosis of Chagas’ Disease and Genotyping of , p 713-725. In Persing D, Tenover F, Tang Y, Nolte F, Hayden R, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555816834.ch47
Generic image for table

Sequence of PCR primers used for analysis

Citation: Svoboda M, Virreira M, Truyens C, Torrico F, Carlier Y. 2011. Molecular Approaches for Diagnosis of Chagas’ Disease and Genotyping of , p 713-725. In Persing D, Tenover F, Tang Y, Nolte F, Hayden R, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555816834.ch47

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error